Sort
82,697 grants matching “vaccine development”
University of Wisconsin Prostate SPORE
$2,085,688David F Jarrard · University Of Wisconsin-Madison · P50 · FY2024 · CA
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$2,085,133Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2016 · DA
Malaria Vaccine: Pfs25-rEPA
$2,085,065Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Plasma Cells in Health and Disease
$2,084,461Ignacio E. Sanz · Emory University · P01 · FY2016 · AI
Broadly Effective HCV Vaccine
$2,083,528Mansun Law · Scripps Research Institute, The · P01 · FY2023 · AI
Broadly Effective HCV Vaccine
$2,083,528Mansun Law · Scripps Research Institute, The · P01 · FY2024 · AI
Intracellular pathogens and innate immunity
$2,082,866Daniel A Portnoy · University Of California Berkeley · P01 · FY2020 · AI
Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)
$2,082,659Amita Gupta · Johns Hopkins University · UM1 · FY2022 · AI
Protective immunity following dengue virus natural infections and vaccination
$2,082,273Eva Harris · University Of California Berkeley · P01 · FY2019 · AI
Modeling Immunity for Biodefense
$2,082,085Hulin Wu · University Of Rochester · N01 · FY2010 · AI
HIV VACCINE TRIAL CLINICAL UNIT
$2,081,737Harvard University (Medical School) · U01 · FY2003 · AI
University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection
$2,081,657Anna Wald · University Of Washington · U19 · FY2021 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,081,637Johns Hopkins University · U01 · FY2003 · AI
Live attenuated vaccines for epidemic and pandemic flu
$2,081,495Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2006 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$2,080,841Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2009 · HG
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Research Activities
$2,080,769Walter Orenstein · Emory University · N01 · FY2021 · AI
New Approaches To Active Immunoprophylaxis
$2,080,655Robert H. Purcell · Niaid Extramural Activities · Z01 · FY2007 · AI
Intracellular pathogens and innate immunity
$2,079,300Daniel A Portnoy · University Of California Berkeley · P01 · FY2019 · AI
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
$2,079,261Sabra L Klein · Johns Hopkins University · U54 · FY2022 · CA
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
$2,079,017Barton F Haynes · Duke University · U19 · FY2018 · AI
Th1 polarizing immune responses using DNA origami
$2,077,682William M Shih · Harvard University · U54 · FY2019 · CA
Establishment and Expansion of SPF Rhesus Colony
$2,077,676Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2012 · OD
Colorado AIDS Clinical Trials Unit
$2,077,607Thomas B. Campbell · University Of Colorado Denver · U01 · FY2010 · AI
Molecular Genetics Of Scrapie Pathogenesis
$2,077,438Suzette Alise Priola · Niaid Extramural Activities · Z01 · FY2007 · AI
Core 5: Integrated Support Services
$2,076,371Ronald B Corley · Boston University Medical Campus · UC7 · FY2022 · AI